Rinsho Shinkeigaku (Clinical Neurology)

  • HOME
  • Rinsho Shinkeigaku (Clinical Neurology)
  • Vol.51 No.11

Vol.51 No.11 contents

Presidential Address

Development of disease-modifying therapy for neurodegenerative diseases

Gen Sobue, M.D.

CLINICA NEUROL, 51: 821|824, 2011

Special Lecture 1

Past, present, and future of polyglutamine expansion disease

Kenneth H. Fischbeck

CLINICA NEUROL, 51: 825|825, 2011

Special Lecture 2

Single molecule meets brain: A new concept to understand complex bio-system

Toshio Yanagida, Ph.D.

CLINICA NEUROL, 51: 826|826, 2011

Educational Lecture 1

Healthcare mediation model for nerologists

Tetsuo Ando, M.D.

CLINICA NEUROL, 51: 827|829, 2011

Educational Lecture 2

Ethical guidelines for clinical studies: overview

Yoshihiko Iijima, M.D., Ph.D.

CLINICA NEUROL, 51: 830|833, 2011

Educational Lecture 3

Pareneoplastic neurological syndrome-update-

Takashi Inuzuka, M.D., Ph.D., Yuichi Hayashi, M.D., Ph.D. and Akio Kimura, M.D., Ph.D.

CLINICA NEUROL, 51: 834|837, 2011

Educational Lecture 4

Multiple system atrophy-synuclein and neuronal degeneration

Mari Yoshida, M.D.

CLINICA NEUROL, 51: 838|842, 2011

Educational Lecture 4

Initial cellular target in multiple system atrophy: Glial cell

Mitsunori Yamada, M.D.

CLINICA NEUROL, 51: 843|843, 2011

Educational Lecture 5

Frontotemporal lobar degeneration (FTLD) concept and classification update

Imaharu Nakano, M.D.

CLINICA NEUROL, 51: 844|847, 2011

Educational Lecture 6

Central nervous system diseases in immunocompromised host

Shuji Kishida, M.D.

CLINICA NEUROL, 51: 848|848, 2011

Educational Lecture 7

Glycobiology and neurological disorders

Tatsuro Mutoh, M.D., Ph.D.

CLINICA NEUROL, 51: 849|852, 2011

Educational Lecture 8

Clinical trial updates for malignant brain tumors

Toshihiko Wakabayashi, M.D., Ph.D.

CLINICA NEUROL, 51: 853|856, 2011

Educational Lecture 9

Pharmacologic therapies of BPSD: messages from psychiatrists

Mamoru Hashimoto, M.D., Ph.D.

CLINICA NEUROL, 51: 857|860, 2011

Educational Lecture 10

Assessment of cognitive and emotional functions in Parkinson's disease

Mitsuru Kawamura, M.D.1), Mutsutaka Kobayakawa, M.D.1)2) and Natsuko Tsuruya, M.D.1)

CLINICA NEUROL, 51: 861|861, 2011

Educational Lecture 11

Secondary prevention of ischemic stroke-Update

Kortaro Tanaka, M.D.

CLINICA NEUROL, 51: 862|862, 2011

Educational Lecture 12

The diagnosis of neurodegenerative disorders based on clinical and pathological findings using an MRI approach

Hirohisa Watanabe, M.D.1), Mari Yoshida, M.D.2), Shinji Naganawa, M.D.3) and Gen Sobue, M.D.1)

CLINICA NEUROL, 51: 863|864, 2011

Educational Lecture 13

Practical genetic counseling conducted by clinical neurologist

Kunihiro Yoshida, M.D.

CLINICA NEUROL, 51: 865|867, 2011

Educational Lecture 14

Significance of COI disclosure in medical research in Japan

Saburo Sone, M.D.

CLINICA NEUROL, 51: 868|871, 2011

Educational Lecture 15

The pathophysiology and treatment of autoimmune neuromuscular junction diseases

Masakatsu Motomura, M.D.

CLINICA NEUROL, 51: 872|876, 2011

Educational Lecture 16

Diagnosis and therapies of refractory migraine

Toshihiko Shimizu, M.D., Ph.D.

CLINICA NEUROL, 51: 877|880, 2011

Symposium 1

Current state of BAD in Japan (Results of J-BAD Registry)

Haruhiko Hoshino, M.D.1), Makoto Takagi, M.D.1), Yasumasa Yamamoto, M.D.2) and J-BAD Investigators

CLINICA NEUROL, 51: 881|881, 2011

Symposium 1

Branch atheromatous disease: an important cause of small subcortical infarction in Asia

Jong Sung Kim

CLINICA NEUROL, 51: 882|882, 2011

Symposium 1

Branch atheromatous disease: prognosis and management.
The SPS3 experience

Oscar Benavente

CLINICA NEUROL, 51: 883|883, 2011

Symposium 2

A drug targeting intracellular amyloid-β and oxidative stress: Apomorphine

Yasumasa Ohyagi, M.D., Ph.D.

CLINICA NEUROL, 51: 884|887, 2011

Symposium 2

Kampo treatment for Alzheimer's disease

Hideo Hara, M.D.1) and Takeshi Tabira, M.D.2)

CLINICA NEUROL, 51: 888|888, 2011

Symposium 2

Molecular chaperone inducer: a possible treatment for Alzheimer disease

Takashi Kudo, M.D.

CLINICA NEUROL, 51: 889|889, 2011

Symposium 2

Monoclonal antibody against the turn of the 42-residue amyloid β-protein at positions 22 and 23

Kazuhiro Irie, Ph.D.1), Kazuma Murakami, Ph.D.1), Yuichi Masuda, Ph.D.1), Nakaba Murata2), Yoshihiro Noda2), Hiroyuki Hatsuta, M.D., Ph.D.2), Shigeo Murayama, M.D., Ph.D.2), Takahiko Shimizu, Ph.D.2), Yuko Horikoshi, Ph.D.3), Noriaki Kinoshita, Ph.D.3) and Takuji Shirasawa, M.D., Ph.D.4)

CLINICA NEUROL, 51: 890|891, 2011

Symposium 3

Disruption of interactions between immunocytes, glia and neurons in demyelinating diseases:a view from neuroscience

Tetsuya Mizuno, M.D.

CLINICA NEUROL, 51: 892|893, 2011

Symposium 3

Aberrant cross talk between immune cells and neural cells in demyelinating disorders

Yuji Nakatsuji, M.D.

CLINICA NEUROL, 51: 894|897, 2011

Symposium 3

Astrocytopathy in neuromyelitis optica, multiple sclerosis and Baló's disease

Takuya Matsushita1), Katsuhisa Masaki2), Satoru Suzuki3), Takeshi Matsuoka2)3), Tomomi Yonekawa2), Xiao-Mu Wu4), Takeshi Tabira5), Toru Iwaki3) and Jun-ichi Kira2)

CLINICA NEUROL, 51: 898|900, 2011

Symposium 4

Registry of muscular dystrophy (Remudy). Construction of the patient self-report registry and collaboration with overseas network

Harumasa Nakamura, M.D.1) and Mitsuru Kawai, M.D.2)

CLINICA NEUROL, 51: 901|902, 2011

Symposium 4

JaCALS: a prospective multicenter ALS cohort study

Naoki Atsuta, Ryoichi Nakamura, Hazuki Watanabe, Hirohisa Watanabe, Mizuki Ito, Jo Senda, Fumiaki Tanaka and Gen Sobue

CLINICA NEUROL, 51: 903|905, 2011

Symposium 4

The cohort study of dementia: the Hisayama study

Yutaka Kiyohara, MD, PhD

CLINICA NEUROL, 51: 906|909, 2011

Symposium 4

Therapeutic trial design issues for future disease-modifying therapy of multiple system atrophy

Yaeko Ichikawa, M.D., Ph.D., Jun Goto, M.D., Ph.D., Yasuo Nakahara, M.D., Ph.D., Jun Mitsui, M.D., Ph.D. and Shoji Tsuji, M.D., Ph.D.

CLINICA NEUROL, 51: 910|913, 2011

Symposium 5

Exon-skipping therapy for Duchenne muscular dystrophy

Shin'ichi Takeda, M.D.

CLINICA NEUROL, 51: 914|916, 2011

Symposium 5

Novel pathomechanism and therapeutic approach for Fukuyama muscular dystrophy

Tatsushi Toda, M.D.

CLINICA NEUROL, 51: 917|917, 2011

Symposium 5

Emerging novel therapeutic strategy for α-dystroglycanopathy by Large

Fumiaki Saito, M.D., Ph.D.

CLINICA NEUROL, 51: 918|921, 2011

Symposium 5

Skeletal muscle regeneration therapy

Yutaka Ohsawa, M.D.

CLINICA NEUROL, 51: 922|922, 2011

Symposium 6

Neuronal mechanisms of functional recovery after spinal cord injury and restoring lost function using artificial neuronal connection

Yukio Nishimura, Ph.D.

CLINICA NEUROL, 51: 923|923, 2011

Symposium 6

Neurorehabilitative intervention with neurofeedback system using functional near-infrared spectroscopy

Masahito Mihara, M.D., Ph.D.

CLINICA NEUROL, 51: 924|926, 2011

Symposium 6

Possibility of Brain-Computer Interface in Neurorehabilitation

Junichi Ushiba, M.D.

CLINICA NEUROL, 51: 927|927, 2011

Symposium 7

Atypical method for understanding dementia. How can studying epigenetics contribute?

Atsushi Iwata, M.D., Ph.D.

CLINICA NEUROL, 51: 928|929, 2011

Symposium 7

Clinical approach to atypical typer of dementia

Kyoko Suzuki, M.D.

CLINICA NEUROL, 51: 930|933, 2011

Symposium 7

Neurodegenerative disease presenting motor speech disorder due to pseudobulbar palsy

Kenji Ishihara, M.D.

CLINICA NEUROL, 51: 934|934, 2011

Symposium 7

Dementia with motor neuron disease

Michael J. Strong1), Wencheng Yang1), May Gohar2) and Wendy L. Strong2)

CLINICA NEUROL, 51: 935|935, 2011

Symposium 8

Neuropathic pain-definition, mechanisms diagnosis and management

Ralf Baron

CLINICA NEUROL, 51: 936|936, 2011

Symposium 8

Central neuropathic pain after surgical resection in patients with spinal intramedullary tumor

Masaya Nakamura, M.D., Osahiko Tsuji, M.D., Naobumi Hosogane, M.D., Kota Watanebe, M.D., Takashi Tsuji, M.D., Ken Ishii, M.D., Yoshiaki Toyama, M.D., Kazuhiro Chiba, M.D. and Morio Matsumoto, M.D.

CLINICA NEUROL, 51: 937|938, 2011

Symposium 8

Conservative therapy for Neuropathic Pain

Takahiro Ushida, M.D., Makoto Nishihara, M.D., Kenichi Arai, M.D. and Shinsuke Inoue, M.D.

CLINICA NEUROL, 51: 939|939, 2011

Symposium 9

Subcortical vascular dementia: Significance in the differential diagnosis of dementia

Hidekazu Tomimoto, M.D.

CLINICA NEUROL, 51: 940|942, 2011

Symposium 9

TGF-β family signaling contributes to human cerebral small vessel disease

Osamu Onodera, M.D., Ph.D.

CLINICA NEUROL, 51: 943|944, 2011

Symposium 9

The pathomechanism and treatment of CADASIL

Makoto Uchino

CLINICA NEUROL, 51: 945|948, 2011

Symposium 10

Brain MRI: differences between 3T and 1.5T

Yukio Miki, M.D.

CLINICA NEUROL, 51: 949|950, 2011

Symposium 10

Researches for diagnostic neuroradiology focusing on signals and shapes

Shoichi Ito, M.D., Ph.D.

CLINICA NEUROL, 51: 951|954, 2011

Symposium 10

Clinical application of diffusion MR imaging of the brain

Shigeki Aoki, M.D.1), Masaaki Hori, M.D.1), Yoshitaka Masutani, M.D.2), Osamu Abe, M.D.3), Koji Kamagata, M.D.1) and Takaaki Hattori, M.D.4)

CLINICA NEUROL, 51: 955|955, 2011

Symposium 11

Attracting the best and brightest to careers in neurology

Donald H. Silberberg

CLINICA NEUROL, 51: 956|956, 2011

Symposium 11

Medical neurology/critical neurology

Fumio Kanda, M.D.

CLINICA NEUROL, 51: 957|957, 2011

Symposium 11

Expert/neurologist∼clinical

Mikio Shoji, M.D.

CLINICA NEUROL, 51: 958|958, 2011

Symposium 11

Disease-oriented neuroscience researcher

Hideki Mochizuki, M.D.

CLINICA NEUROL, 51: 959|959, 2011

Symposium 12

Myositis-specific and associated autoantibodies

Masataka Kuwana, M.D.

CLINICA NEUROL, 51: 960|960, 2011

Symposium 12

Anti-SRP myopathy

Shigeaki Suzuki, M.D., Ph.D.

CLINICA NEUROL, 51: 961|963, 2011

Symposium 12

Pathomechanism and prevalence of sporadic inclusion body myositis (sIBM)

Naoki Suzuki, M.D.1), Maki Tateyama, M.D.1), Hitoshi Warita, M.D.1), Rumiko Izumi, M.D.1), Ichizo Nishino, M.D.2) and Masashi Aoki, M.D.1)

CLINICA NEUROL, 51: 964|966, 2011

Symposium 12

Immunotherapy of myositis: Future prospects

Jun Shimizu, M.D.

CLINICA NEUROL, 51: 967|967, 2011

Symposium 13

Overview for personal genome analysis

Tatsushi Toda, M.D.1) and Shoji Tsuji, M.D.2)

CLINICA NEUROL, 51: 968|968, 2011

Symposium 13

Perspectives of personal genome information analysis

Shinichi Morishita, M.D.

CLINICA NEUROL, 51: 969|969, 2011

Symposium 13

Next-generation analysis on hereditary neurodegenerative disorders using next-generation sequencers

Hiroyuki Ishiura, M.D., Ph.D.1)2) and Shoji Tsuji, M.D., Ph.D.1)

CLINICA NEUROL, 51: 970|972, 2011

Symposium 13

Genetics of sporadic disease: insights from high-throughput sequencing-Parkinson disease-

Jun Mitsui, M.D.

CLINICA NEUROL, 51: 973|974, 2011

Symposium 13

Ethical issues of personal genome research

Kazuto Kato, Ph.D

CLINICA NEUROL, 51: 975|975, 2011

Symposium 14

Neurodegeration based on polyglutamine aggregation

Nobuyuki Nukina, M.D.

CLINICA NEUROL, 51: 976|978, 2011

Symposium 14

DNA repair and neurodegeneration: a common pathology shared by polyglutamine diseases

Hitoshi Okazawa, M.D.

CLINICA NEUROL, 51: 979|981, 2011

Symposium 14

TGF-beta signaling in neurodegenerative diseases

Masahisa Katsuno, M.D.1), Haruhiko Banno, M.D.1)2), Keisuke Suzuki, M.D.1) ,Hiroaki Adachi, M.D.1), Fumiaki Tanaka, M.D.1) and Gen Sobue, M.D.1)

CLINICA NEUROL, 51: 982|985, 2011

Symposium 14

The pathomechanisms of young-onset Parkinson's disease (PD), approach to the causes of PD form the mechanisms of insulin secretion system

Nobutaka Hattori, M.D.1), Hiroto Eguchi, M.D.1), Mika Imaizumi, Ph.D.2), Shinji Saiki, M.D.1), Shigeto Sato, M.D.1) and Shinya Nagamatsu, M.D.2)

CLINICA NEUROL, 51: 986|987, 2011

Symposium 14

Neurodegenerative disorder as "mitochondrial dysfunction disease"

Noriyuki Matsuda, Ph.D. and Keiji Tanaka, M.D.

CLINICA NEUROL, 51: 988|988, 2011

Symposium 15

Management of adult patients with childhood-onset epilepsy by child neurologists and adult neurologists

Yoko Ohtsuka, M.D.

CLINICA NEUROL, 51: 989|989, 2011

Symposium 15

Vagus nerve stimulation for epilepsy

Kensuke Kawai, M.D., Ph.D., Kenichi Usami, M.D. and Nobuhito Saito, M.D., Ph.D.

CLINICA NEUROL, 51: 990|992, 2011

Symposium 15

The leading edge of epilepsy research

Akio Ikeda, M.D., Ph.D.

CLINICA NEUROL, 51: 993|996, 2011

Symposium 15

An adult neurologist's update on epilepsy therapy

Hiroshi Shigeto, M.D., Ph.D.

CLINICA NEUROL, 51: 997|999, 2011

Symposium 16

Guidelines for atrial fibrillation and the "Real World"

Takeshi Yamashita, M.D.

CLINICA NEUROL, 51: 1000|1000, 2011

Symposium 16

Atrial fibrillation and cardiembolic stroke. Treatment and issue in acute phase

Masahiro Yasaka

CLINICA NEUROL, 51: 1001|1003, 2011

Symposium 16

Expectation to and problems of thrombin inhibitor

Shinichiro Uchiyama

CLINICA NEUROL, 51: 1004|1006, 2011

Symposium 16

Current status and future of anti-Xa inhibitors

Takehiko Nagao, M.D.

CLINICA NEUROL, 51: 1007|1010, 2011

Symposium 17

Perspectives in refractory diabetic and amyloid small-fiber neuropathy

Gerard Said

CLINICA NEUROL, 51: 1011|1011, 2011

Symposium 17

Therapeutic responsiveness in chronic inflammatory demyelinating polyradiculoneuropathy

Masahiro Iijima, M.D.

CLINICA NEUROL, 51: 1012|1014, 2011

Symposium 17

Therapeutic strategies for Charcot-Marie-Tooth disease

Masanori Nakagawa, M.D.

CLINICA NEUROL, 51: 1015|1018, 2011

Symposium 17

Treatment for Crow-Fukase (POEMS) syndrome

Satoshi Kuwabara, M.D.

CLINICA NEUROL, 51: 1019|1019, 2011

Symposium 17

Artificial control of blood-nerve barrier: a novel therapeutic approach to peripheral neuropathies

Takashi Kanda, M.D.

CLINICA NEUROL, 51: 1020|1022, 2011

Symposium 18

Care network supporting patients with intractable diseases

Jun-ichi Kira, M.D.

CLINICA NEUROL, 51: 1023|1023, 2011

Symposium 18

Several approaches for quality of life in intractable disease

Tetsuo Komori, M.D., Ph.D.

CLINICA NEUROL, 51: 1024|1026, 2011

Symposium 18

Countermeasures against natural disasters for patients with neurological intractable disases at home

Masatoyo Nishizawa

CLINICA NEUROL, 51: 1027|1028, 2011

Symposium 18

Report on the actual situation at centers offering support for intractable diseases and wide-area helicopter transport of ALS patiants on mechanical ventilation at The Great East Japan Earthquake

Takashi Imai

CLINICA NEUROL, 51: 1029|1030, 2011

Symposium 19

Alzheimer's disease and microglia

Makoto Higuchi, M.D., Ph.D.1), Bin Ji, Ph.D.1), Jun Maeda, Ph.D.1), Masahiro Maruyama, M.D., Ph.D.1), Maiko Ono, M.S.1), Makoto Sawada, Ph.D.2) and Tetsuya Suhara, M.D., Ph.D.1)

CLINICA NEUROL, 51: 1031|1031, 2011

Symposium 19

Astroglial protective mechanisms against ROS under brain ischemia

Shinichi Takahashi, M.D.

CLINICA NEUROL, 51: 1032|1035, 2011

Symposium 19

Demyelination and oligodendrocytes

Takayuki Itoh, M.D., Ph.D., Makoto Horiuchi, Ph.D., Kouji Wakayama, M.D., Ph.D., Aki Itoh, Ph.D. and David Pleasure, M.D.

CLINICA NEUROL, 51: 1036|1039, 2011

Symposium 20

Infection of herpes simplex virus-Clinical diagnosis and treatment for herpes virus encephalitis-

Satoshi Kamei, M.D.

CLINICA NEUROL, 51: 1040|1043, 2011

Symposium 20

Clinical diversity of HAM/TSP

Ryuji Kubota, M.D.

CLINICA NEUROL, 51: 1044|1046, 2011

Symposium 20

Subacute sclerosing panencephalitis (SSPE)

Mitsuaki Hosoya

CLINICA NEUROL, 51: 1047|1050, 2011

Symposium 20

Progressive multifocal leukoencephalopathyiPMLj

Hidehiro Mizusawa, M.D., Ph.D.1), Shuji Kishida, M.D., Ph.D.2), Masayuki Saijo, M.D., Ph.D.3), Motohiro Yukishita, M.D., Ph.D.4), Yukiko Shishido-Hara, M.D., Ph.D.5), Hirohumi Sawa, M.D., Ph.D.6), Kazuo Nagashima, M.D., Ph.D.7), Souichi Nukuzuma, Ph.D.8) and Masahito Yamada, M.D., Ph.D.9)

CLINICA NEUROL, 51: 1051|1057, 2011

Symposium 21

Neurorehabilitation and neural mechanisms underlying functional recovery after brain damage

Ichiro Miyai, M.D.

CLINICA NEUROL, 51: 1058|1058, 2011

Symposium 21

Fundamental theory and practice in stroke rehabilitation from acute stage to chronic stage

Hiroyoshi Hara, M.D.

CLINICA NEUROL, 51: 1059|1062, 2011

Symposium 21

Neuro-rehabilitation for neurological disease

Yukihiro Hara, M.D.

CLINICA NEUROL, 51: 1063|1065, 2011

Symposium 22

Treatment and management for severe dysphagia: medication, rehabilitation and surgery

Ichiro Fujishima, M.D.

CLINICA NEUROL, 51: 1066|1068, 2011

Symposium 22

Dysphagia with lateral medullary infarction (Wallenberg's syndrome)

Fumiko Oshima, M.D.

CLINICA NEUROL, 51: 1069|1071, 2011

Symposium 22

Evaluation and treatment of dysphagia in amyotrophic lateral sclerosis and Parkinson's disease

Toshiyuki Yamamoto, Ph.D.

CLINICA NEUROL, 51: 1072|1074, 2011

Symposium 23

Cell therapy for brain diseases: Perspective and future prospects

Ryosuke Takahashi, M.D. and Takayuki Kondo, M.D.

CLINICA NEUROL, 51: 1075|1077, 2011

Symposium 23

Neurodegenerative disease-specific induced pluripotent stem cell research

Haruhisa Inoue, M.D., Ph.D.

CLINICA NEUROL, 51: 1078|1078, 2011

Symposium 23

Evaluation of human iPS cells by neural differentiation and tumorigenicity

Yohei Okada, M.D., Ph.D.1)2) and Hideyuki Okano, M.D., Ph.D.2)

CLINICA NEUROL, 51: 1079|1080, 2011

Symposium 23

Cell based therapy for patients after cerebral embolism

Akihiko Taguchi, Kozue Saito, Katsufumi Kajimoto, Hiroshi Moriwaki, Yukiko Kasahara, Hiroaki Naritomi, Kotaro Miyashita and Kazuyuki Nagatsuka

CLINICA NEUROL, 51: 1081|1082, 2011

Symposium 24

Nurturing clinician investigators is the best way to innovative drug development from academia

Shunichi Fukuhara, M.D.

CLINICA NEUROL, 51: 1083|1083, 2011

Symposium 24

Drug discovery and development in academia

Toshio Miyata, M.D.

CLINICA NEUROL, 51: 1084|1084, 2011

Symposium 24

Current situation and future perspective for clinical trials in Japan

Katsuhiko Ichimaru

CLINICA NEUROL, 51: 1085|1085, 2011

Symposium 25

Overview: Diagnosis of vestibular syndromes

Genjiro Hirose, M.D., Ph.D.

CLINICA NEUROL, 51: 1086|1088, 2011

Symposium 25

Recent advancement of BPPV management

Mamoru Suzuki

CLINICA NEUROL, 51: 1089|1091, 2011

Symposium 25

Dizziness/vertigo caused by small cerebellar/brainstem strokes

Ken Johkura, M.D., Ph.D.

CLINICA NEUROL, 51: 1092|1095, 2011

Symposium 25

Human vestibular cortex

Yasushi Naito, M.D.

CLINICA NEUROL, 51: 1096|1096, 2011

Symposium 26

Seed, aggregation and propagation of abnormal proteins could explain neurodegeneration?

Shigeo Murayama, M.D., Ph.D.

CLINICA NEUROL, 51: 1097|1099, 2011

Symposium 26

The infectivity of protein misfolding diseases is reviewed by a prion disease researcher

Tetsuyuki Kitamoto, M.D.

CLINICA NEUROL, 51: 1100|1100, 2011

Symposium 26

Protein cancers hypothesis for neurodegenerative diseases

Masato Hasegawa

CLINICA NEUROL, 51: 1101|1104, 2011

Symposium 26

Cross-seeding hypothesis for mental disorders in Huntington disease-Implications from prion diseases to neuropsychiatric diseases

Motomasa Tanaka, Ph.D., Yoko Nekooki, M.S., Yusuke Komi, Ph.D. and Ryo Endo, Ph.D.

CLINICA NEUROL, 51: 1105|1105, 2011

Symposium 27

Pathophysiological roles of autophagy

Masaaki Komatsu, M.D.

CLINICA NEUROL, 51: 1106|1106, 2011

Symposium 27

The enhancement of protein degradation systems exerts therapeutic effects in the polyglutamine-mediated motor neuron disease

Hiroaki Adachi, M.D.

CLINICA NEUROL, 51: 1107|1107, 2011

Symposium 27

Selective degradation of expanded polyglutamine proteins by their specific recognition with QBP1

Yoshitaka Nagai, M.D., Ph.D.1) and Nobuyuki Nukina, M.D., Ph.D.2)

CLINICA NEUROL, 51: 1108|1110, 2011

Symposium 28

Electrodiagnosis of ALS: its practical aspects

Masahiro Sonoo, M.D.1), Mana Higashihara, M.D.2) and Keiichi Hokkoku, M.D.1)

CLINICA NEUROL, 51: 1111|1113, 2011

Symposium 28

Increased variability of membrane potentials in amyotrophic lateral sclerosis

Yoshimitsu Shimatani, M.D.1), Yoshiko Shibuta, M.D.1), Hiroyuki Nodera, M.D.1)2), Atsuko Nodera, M.D., Ph.D.1), Kotaro Asanuma, M.D., Ph.D.1), Yuishin Izumi, M.D., Ph.D.1) and Ryuji Kaji, M.D., Ph.D.1)

CLINICA NEUROL, 51: 1114|1117, 2011

Symposium 28

Motor axonal excitability properties are strong predictors for survival in amyotrophic lateral sclerosis

Kazuaki Kanai, M.D., Kazumoto Shibuya, M.D. and Satoshi Kuwabara, M.D.

CLINICA NEUROL, 51: 1118|1119, 2011

Symposium 28

Electrophysiological findings in TDP-43 over-expressed animal models

Takanori Yokota, M.D.

CLINICA NEUROL, 51: 1120|1120, 2011

Symposium 29

Physiological analysis of the cerebellum: Roles in temporal processing

Masaki Tanaka, M.D., Ph.D., Shogo Ohmae, M.D., Ph.D. and Akiko Uematsu, B.Pharin.

CLINICA NEUROL, 51: 1121|1121, 2011

Symposium 29

Dissecting molecular mechanism of spinocerebellar ataxia type 31

Kinya Ishikawa, M.D.1), Yusuke Niimi, M.D.1), Nozomu Sato, M.D.1), Takeshi Amino, M.D.1)2) and Hidehiro Mizusawa, M.D.1)

CLINICA NEUROL, 51: 1122|1124, 2011

Symposium 29

Hereditary spastic paraplegia in Japan

Yoshihisa Takiyama, M.D.

CLINICA NEUROL, 51: 1125|1128, 2011

Symposium 29

Intensive neurorehabilitation improves motor function in patients with spinocerebellar degeneration

Ichiro Miyai, M.D.

CLINICA NEUROL, 51: 1129|1129, 2011

Symposium 30

Epidemiological and clinical aspects of non-hereditary systemic amyloidosis

Yoshiki Sekijima, M.D., Ph.D.

CLINICA NEUROL, 51: 1130|1133, 2011

Symposium 30

Clinicopathological features of familial amyloid polyneuropathy

Haruki Koike and Gen Sobue

CLINICA NEUROL, 51: 1134|1137, 2011

Symposium 30

Effect of liver trasplantation on familial amyloidotic polyneuropathy (FAP) and its limt

Yukio Ando, M.D., PhD

CLINICA NEUROL, 51: 1138|1141, 2011

Symposium 30

Cerebral amyloid angiopathy: pathogenesis and clinical features

Masahito Yamada, M.D.

CLINICA NEUROL, 51: 1142|1142, 2011

Symposium 30

Metabolic turn over of amyloid fibrils and post-treatment regression of amyloid deposits in systemic amyloidosis with polyneuropathy

Shu-ichi Ikeda, M.D.

CLINICA NEUROL, 51: 1143|1145, 2011

Symposium 31

Mechanism of chronification of migraine

Norihiro Suzuki, M.D.

CLINICA NEUROL, 51: 1146|1146, 2011

Symposium 31

Clinical course and natural history in migraine

Hisanori Kowa, M.D., Ph.D. and Kenji Nakashima, M.D., Ph.D.

CLINICA NEUROL, 51: 1147|1149, 2011

Symposium 31

Treatment of refractory medication overuse headache

Junichi Hamada, M.D.

CLINICA NEUROL, 51: 1150|1152, 2011

Symposium 31

Psychosomatic approach for chronic migraine

Masahiro Hashizume

CLINICA NEUROL, 51: 1153|1155, 2011

Symposium 32

Antibody treatment for multiple sclerosis and neuromyeitis optica

Takashi Yamamura, M.D.

CLINICA NEUROL, 51: 1156|1156, 2011

Symposium 32

Anti-myostatin antibody therapy for myopathies

Yoshihide Sunada, M.D.

CLINICA NEUROL, 51: 1157|1159, 2011

Symposium 32

Antibody therapy for Alzheimer's disease

Takeshi Tabira, Shin-ei Matsumoto and Haifeng Jin

CLINICA NEUROL, 51: 1160|1161, 2011

Symposium 32

Antibody therapy targeting ALS-linked misfolded protein

Makoto Urushitani, M.D., Ph.D.

CLINICA NEUROL, 51: 1162|1164, 2011

Symposium 33

Pathophysiology and clinical presentation of Parkinson's disease-up to date pathomechanisms of Parkinson's disease

Takafumi Hasegawa, M.D.

CLINICA NEUROL, 51: 1165|1167, 2011

Symposium 33

Neuropathology

Yuko Saito, M.D., Ph.D.1) and Shigeo Murayama, M.D., Ph.D.2)

CLINICA NEUROL, 51: 1168|1171, 2011

Symposium 33

Up to date on Parkinson's disease-Therapy-

Taku Hatano, M.D.

CLINICA NEUROL, 51: 1172|1172, 2011

Symposium 34

Cerebral infarction: tissue clock and reperfusion, brief overview

Shinichi Takahashi, M.D.

CLINICA NEUROL, 51: 1173|1173, 2011

Symposium 34

The extension of time window until 4.5 hours and development of MRI in t-PA patients

Kazumi Kimura, M.D., Yuki Sakamoto, M.D. and Junya Aoki, M.D.

CLINICA NEUROL, 51: 1174|1176, 2011

Symposium 34

CLINICA NEUROL, 51: 1177|1177, 2011

Symposium 34

Proton magnetic resonance spectroscopy as a time clock measurement device in cerebral ischemia

Hironaka Igarashi, M.D., Ph.D.

CLINICA NEUROL, 51: 1178|1181, 2011

Symposium 34

Therapeutic time window for ischemic stroke

Koji Abe, M.D., Ph.D.

CLINICA NEUROL, 51: 1182|1184, 2011

Symposium 35

Molecular neuropathology of neurodegeneration by TDP-43

Takashi Nonaka, Ph.D. and Masato Hasegawa, Ph.D.

CLINICA NEUROL, 51: 1185|1185, 2011

Symposium 35

BSCL2-related neurologic disorders/seipinopathy: endoplasmic reticulum stress in neurodegeneration

Daisuke Ito, M.D., Takuya Yagi, M.D. and Norihiro Suzuki, M.D.

CLINICA NEUROL, 51: 1186|1188, 2011

Symposium 35

Role of axonal transport in ALS

Fumiaki Tanaka, M.D., Kensuke Ikenaka, M.D. and Gen Sobue, M.D.

CLINICA NEUROL, 51: 1189|1191, 2011

Symposium 35

Glial pathology in amyotrophic lateral sclerosis

Koji Yamanaka, M.D.

CLINICA NEUROL, 51: 1192|1194, 2011

Symposium 35

Regenerative therapies for amyotrophic lateral sclerosis using hepatocyte growth factor

Masashi Aoki, M.D., Hitoshi Warita, M.D., Naoki Suzuki, M.D., Masaaki Kato, M.D. and Yasuto Itoyama, M.D.

CLINICA NEUROL, 51: 1195|1198, 2011